Evaluation and treatment of seizures in patients with systemic lupus erythematosus

Bruce Mayes, Robin L Brey

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Seizures associated with systemic lupus erythematosus (SLE) occur in 9 to 58% of patients in reported series, often early in the disease course. Approximately half of seizures reported in SLE patients are associated with infection and with metabolic or iatrogenic complications. However, in clinical practice, this number might be much larger, as relatively few prospective studies are available. The seizure type in nearly 75% of SLE patients is generalized tonic-clonic. These often begin with and recur, even without anticonvulsant treatment, only during an SLE disease flare. In contrast, seizures in SLE patients with a focal onset often recur without anticonvulsant treatment, irrespective of SLE disease activity. This review offers a practical diagnostic and management approach to the SLE patient with new or recurrent seizures and takes into consideration the effects of immunosuppressive therapy and multi-organ failure. This approach is based on a synthesis of the literature regarding seizures and epilepsy in SLE patients and on the authors' personal experience.

Original languageEnglish (US)
Pages (from-to)336-345
Number of pages10
JournalJournal of Clinical Rheumatology
Volume2
Issue number6
StatePublished - Dec 1996

Fingerprint

Systemic Lupus Erythematosus
Seizures
Therapeutics
Anticonvulsants
Immunosuppressive Agents
Epilepsy
Prospective Studies
Infection

Keywords

  • Autoantibodies
  • Neuropsychiatric manifestations
  • Seizures
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Evaluation and treatment of seizures in patients with systemic lupus erythematosus. / Mayes, Bruce; Brey, Robin L.

In: Journal of Clinical Rheumatology, Vol. 2, No. 6, 12.1996, p. 336-345.

Research output: Contribution to journalArticle

@article{5bf2922fed214f54bcf0ac76ee12ed67,
title = "Evaluation and treatment of seizures in patients with systemic lupus erythematosus",
abstract = "Seizures associated with systemic lupus erythematosus (SLE) occur in 9 to 58{\%} of patients in reported series, often early in the disease course. Approximately half of seizures reported in SLE patients are associated with infection and with metabolic or iatrogenic complications. However, in clinical practice, this number might be much larger, as relatively few prospective studies are available. The seizure type in nearly 75{\%} of SLE patients is generalized tonic-clonic. These often begin with and recur, even without anticonvulsant treatment, only during an SLE disease flare. In contrast, seizures in SLE patients with a focal onset often recur without anticonvulsant treatment, irrespective of SLE disease activity. This review offers a practical diagnostic and management approach to the SLE patient with new or recurrent seizures and takes into consideration the effects of immunosuppressive therapy and multi-organ failure. This approach is based on a synthesis of the literature regarding seizures and epilepsy in SLE patients and on the authors' personal experience.",
keywords = "Autoantibodies, Neuropsychiatric manifestations, Seizures, Systemic lupus erythematosus",
author = "Bruce Mayes and Brey, {Robin L}",
year = "1996",
month = "12",
language = "English (US)",
volume = "2",
pages = "336--345",
journal = "Journal of Clinical Rheumatology",
issn = "1076-1608",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Evaluation and treatment of seizures in patients with systemic lupus erythematosus

AU - Mayes, Bruce

AU - Brey, Robin L

PY - 1996/12

Y1 - 1996/12

N2 - Seizures associated with systemic lupus erythematosus (SLE) occur in 9 to 58% of patients in reported series, often early in the disease course. Approximately half of seizures reported in SLE patients are associated with infection and with metabolic or iatrogenic complications. However, in clinical practice, this number might be much larger, as relatively few prospective studies are available. The seizure type in nearly 75% of SLE patients is generalized tonic-clonic. These often begin with and recur, even without anticonvulsant treatment, only during an SLE disease flare. In contrast, seizures in SLE patients with a focal onset often recur without anticonvulsant treatment, irrespective of SLE disease activity. This review offers a practical diagnostic and management approach to the SLE patient with new or recurrent seizures and takes into consideration the effects of immunosuppressive therapy and multi-organ failure. This approach is based on a synthesis of the literature regarding seizures and epilepsy in SLE patients and on the authors' personal experience.

AB - Seizures associated with systemic lupus erythematosus (SLE) occur in 9 to 58% of patients in reported series, often early in the disease course. Approximately half of seizures reported in SLE patients are associated with infection and with metabolic or iatrogenic complications. However, in clinical practice, this number might be much larger, as relatively few prospective studies are available. The seizure type in nearly 75% of SLE patients is generalized tonic-clonic. These often begin with and recur, even without anticonvulsant treatment, only during an SLE disease flare. In contrast, seizures in SLE patients with a focal onset often recur without anticonvulsant treatment, irrespective of SLE disease activity. This review offers a practical diagnostic and management approach to the SLE patient with new or recurrent seizures and takes into consideration the effects of immunosuppressive therapy and multi-organ failure. This approach is based on a synthesis of the literature regarding seizures and epilepsy in SLE patients and on the authors' personal experience.

KW - Autoantibodies

KW - Neuropsychiatric manifestations

KW - Seizures

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=0030443031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030443031&partnerID=8YFLogxK

M3 - Article

C2 - 19078099

AN - SCOPUS:0030443031

VL - 2

SP - 336

EP - 345

JO - Journal of Clinical Rheumatology

JF - Journal of Clinical Rheumatology

SN - 1076-1608

IS - 6

ER -